CD9 protein in glioblastoma: Implications for progression and therapeutic strategies
Elvira Mª Carbonell, Julia Lara Gutiérrez Arroyo, Conrado Martinez Cadenas, Luis Germán González Bonet, Pía Gallego Porcar, Mª Ángeles Marqués Torrejón · FENS Forum 2024
This study delves into the complexities of glioblastoma multiforme (GBM), a highly aggressive brain cancer, with a particular focus on understanding the role of CD9, a transmembrane protein involved in tumor cell invasion, apoptosis, and resistance to chemotherapy. GBM presents major challenges due to its rapid progression and resistance to conventional treatments. Using immunocytochemistry, CD9 is used as a marker to identify distinct cell populations within GBM cultures. Simultaneously, the study investigates CD9 expression patterns by flow cytometry, providing valuable insights into its pot
ePoster · Neuroscience